154 related articles for article (PubMed ID: 2986665)
1. Neural markers in carcinoma of the lung.
Dhillon AP; Rode J; Dhillon DP; Moss E; Thompson RJ; Spiro SG; Corrin B
Br J Cancer; 1985 May; 51(5):645-52. PubMed ID: 2986665
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical demonstration of neuron-specific enolase (NSE) in human lung cancers.
Bergh J; Esscher T; Steinholtz L; Nilsson K; Påhlman S
Am J Clin Pathol; 1985 Jul; 84(1):1-7. PubMed ID: 2409790
[TBL] [Abstract][Full Text] [Related]
3. [Clinical investigation of neuron-specific enolase, squamous cell carcinoma-related antigen and carcinoembryonic antigen in carcinoma of the lung].
Tashiro T; Nagai H; Yamasaki H; Kuroda Y; Goto Y; Goto J; Nasu M
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2383-8. PubMed ID: 3015044
[TBL] [Abstract][Full Text] [Related]
4. 'Neuroendocrine' differentiation in primary neoplasms of the liver.
Wang JH; Dhillon AP; Sankey EA; Wightman AK; Lewin JF; Scheuer PJ
J Pathol; 1991 Jan; 163(1):61-7. PubMed ID: 1848288
[TBL] [Abstract][Full Text] [Related]
5. PGP 9.5, a new marker for human neuroendocrine tumours.
Rode J; Dhillon AP; Doran JF; Jackson P; Thompson RJ
Histopathology; 1985 Feb; 9(2):147-58. PubMed ID: 2580771
[TBL] [Abstract][Full Text] [Related]
6. [Neuron-specific enolase in bronchial carcinoma. Immunohistochemical and immunoenzyme study].
Leonardo E; Dogliotti C; Oliaro A
Minerva Med; 1986 May; 77(22-23):977-80. PubMed ID: 3014380
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical localization of neuron specific enolase in small cell carcinomas and carcinoid tumours of the lung.
Sheppard MN; Corrin B; Bennett MH; Marangos PJ; Bloom SR; Polak JM
Histopathology; 1984 Mar; 8(2):171-81. PubMed ID: 6202617
[TBL] [Abstract][Full Text] [Related]
8. Endocrine differentiation of extra-pulmonary small cell carcinoma demonstrated by immunohistochemistry using antibodies to PGP 9.5, neuron-specific enolase and the C-flanking peptide of human pro-bombesin.
Springall DR; Ibrahim NB; Rode J; Sharpe MS; Bloom SR; Polak JM
J Pathol; 1986 Nov; 150(3):151-62. PubMed ID: 3027289
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical markers of small cell carcinoma and related neuroendocrine tumours of the lung.
Addis BJ; Hamid Q; Ibrahim NB; Fahey M; Bloom SR; Polak JM
J Pathol; 1987 Oct; 153(2):137-50. PubMed ID: 2826741
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of neuron-specific enolase as a new tumor marker for carcinoma of the lung].
Ariyoshi Y
Gan No Rinsho; 1984 May; 30(6 Suppl):569-73. PubMed ID: 6086970
[TBL] [Abstract][Full Text] [Related]
11. Immunodetection of neuron-specific enolase and keratin in cytological preparations as an aid in the differential diagnosis of lung cancer.
Kyrkou KA; Iatridis SG; Athanassiadou PP; Lambropoulou S; Liossi A
Diagn Cytopathol; 1986 Sep; 2(3):217-20. PubMed ID: 2429809
[TBL] [Abstract][Full Text] [Related]
12. [Serum neuron-specific enolase as a marker of lung cancers].
Fujisawa T; Yamaguchi Y; Sasaki K; Fukazawa T; Hongo H; Ogawa T; Kimura H
Gan To Kagaku Ryoho; 1985 Jan; 12(1):139-43. PubMed ID: 2981514
[TBL] [Abstract][Full Text] [Related]
13. [Neuron-specific enolase (NSE) and squamous cell carcinoma antigen (SCC) as serum markers in the diagnosis of bronchial carcinoma].
Lorenz J; Gillmann-Blum D; Jensen M; Kreienberg R
Pneumologie; 1990 Nov; 44(11):1259-63. PubMed ID: 2177891
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of both neuron-specific enolase (NSE) and Cyfra21-1 in small cell lung cancer.
Ando S; Suzuki M; Yamamoto N; Iida T; Kimura H
Anticancer Res; 2004; 24(3b):1941-6. PubMed ID: 15274381
[TBL] [Abstract][Full Text] [Related]
15. Technical performance and diagnostic utility of the new Elecsys neuron-specific enolase enzyme immunoassay.
Muley T; Ebert W; Stieber P; Raith H; Holdenrieder S; Nagel D; Fürst H; Roth HJ; Luthe H; Blijenberg BG; Gurr E; Uhl W; von Pawel J; Drings P
Clin Chem Lab Med; 2003 Jan; 41(1):95-103. PubMed ID: 12636057
[TBL] [Abstract][Full Text] [Related]
16. Neuron-specific enolase in small-cell carcinoma of the lung: the value of combined immunocytochemistry and serum determination.
Esscher T; Bergh J; Steinholtz L; Nöu E; Nilsson K; Påhlman S
Anticancer Res; 1989; 9(6):1717-20. PubMed ID: 2560624
[TBL] [Abstract][Full Text] [Related]
17. The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer.
Graziano SL; Mazid R; Newman N; Tatum A; Oler A; Mortimer JA; Gullo JJ; DiFino SM; Scalzo AJ
J Clin Oncol; 1989 Oct; 7(10):1398-406. PubMed ID: 2550590
[TBL] [Abstract][Full Text] [Related]
18. [Neuron-specific enolase as a new tumor marker].
Ariyoshi Y; Kato K; Ishiguro Y; Ota K; Sato T; Suchi T
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1744-53. PubMed ID: 6349546
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas.
Linnoila RI; Mulshine JL; Steinberg SM; Funa K; Matthews MJ; Cotelingam JD; Gazdar AF
Am J Clin Pathol; 1988 Dec; 90(6):641-52. PubMed ID: 2848408
[TBL] [Abstract][Full Text] [Related]
20. [The "neuron-specific enolase" tumor marker as a prognostic indicator in small cell bronchial carcinoma].
Hoster M; Kirchheiner T; Rühle KH
Pneumologie; 1995 Aug; 49(8):470-4. PubMed ID: 7479642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]